Blockchain in Healthcare Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Blockchain in Healthcare Market Trends & Drivers

Rising Demand for Distributed Ledger Technology Is Driving Market

• The rising number of instances of information infringement, burglaries, and release of delicate clinical data from computerized databases without prior permission is projected to drive the development of the market over the forecast period.
• Moreover, the fast advancement in the healthcare sector has prompted the adoption of electronic records containing personalized medical care data sets over non-electronic-based clinical records.
• In any case, ordinary data sets, for example, SQL data sets, can obstruct the flow of information because of the centralized database.
• The blockchain technology effectively prevents data breaches with the decentralized character distribution control it offers.
• Furthermore, inaccuracy on the blockchain must be checked with other information, so that the two blocks can be displayed to every user.
• This ensures strength and prevents damage to and the breach of data.
• Hence, pharmaceutical companies are expanding their usage of DLTs for the tracking of the supply chain alongside, and the manufacturers all the way to research laboratories and consumers.
• The maintenance of the records of the products that are supplied over a specific period becomes easy.
• The digitization of the supply chains has prompted the easy trade of fake medications, which can cause more harm than benefit and even death.
• According to the World Health Organization (WHO), one in each 10 medicines fails in low- and middle-income countries because they are substandard or falsified.
• For example, between 72,430 and 169,270 children die of pneumonia each year after taking fake medicines.
• The worldwide concerns about fake medication supply chains have urged the medical community’s change to blockchain to satisfy the user about the manufacturer’s authentication by regulatory bodies.
• In addition, the acceptance of electronic health records (EHRs) has expanded the opportunity for medical practitioners related to the sharing of clinical information to speed up the diagnosis of diseases.
• Furthermore, social platforms that are available commercially are not safe for sharing such important information.
• Thus, the market is projected to grow due to the rapid adoption of blockchains to provide a protected platform for encrypted information sharing that only authenticated users can view. Implementation of Blockchains in Pharmaceutical Supply Chain.

Lack of Awareness and Implementation Challenges Hamper Market Growth

• The true influence of blockchain on healthcare and life sciences industry is yet to be determined.
• Several industry players and healthcare organizations are aware about blockchain technology, given the hype being built around it; however, many of them lack proper understating of how it works and its implications.
• Healthcare industry deals with highly regulated information including personal health information and classified research.
• Organizations are also apprehensive about security issues, deterring its adoption in healthcare and life sciences industries.
• There is lot of scepticism in the market regarding its success and whether it would ultimately give results as expected in long run.
• Implementation of blockchain is expensive, since advanced digital and technical infrastructure is required for the same.
• Also, there are some concerns regarding its integration with the existing technology, such as compatibility with the traditional EHR system.
• The healthcare industry is known to be being overly risk adverse.
• The inherent caution in applying new technologies coupled with the immaturity of the technology and absence of validated full-scale operational projects is restraining its adoption and integration in the healthcare industry.
• Lack of skilled staffs, and interoperability issues (integration of two or more blockchain systems) are also hampering blockchain development and adoption in the healthcare and life sciences industries.

Segmentation and Category Analysis

Type Insights

The public category dominated the market in 2024 with 60% share, due to the rising application of public networks for the management of various particulars. Public blockchains, such as Ethereum, Bitcoin, and Monero, have gained attention because they are truly decentralized and democratized and offer authority-free operation. Because public ledgers allow users to see and confirm data, people are able to trust them for clinical trials, patient records, and other critical applications. The decentralized nature of these blockchains prevent loss of access in case a centralized storage server malfunctions or is breached by unauthorized entities.

The private category will show the fastest growth in the forecast period because these variants offer privacy, fast transactions, and high security, and they are designed according to requirements. Because they restrict access, the ensure the data is visible only to verified entities. This enables better compliance with consumer data protection regulations, such as the GDPR and HIPAA.

These types are covered:

• Private (Fastest-Growing Category)
• Public (Largest Category)
• Others

Application Insights

Drug supply chain management dominated the market in 2024. This is attributed to the development of new approaches to manufacturing and distributing products, such as technologies that can track the whole lifecycle of the drugs, down to a single dose. This helps preserve and exchange patient information across hospitals, diagnostic laboratories, and physicians.

The drug discovery and clinical trials category is expected to show the fastest growth during the forecast period, with 54% CAGR. This is because clinical trials necessitate the collection, sharing, and analysis of figures and stats all in a confidential way. Hence, the rising demand for technologies to ensure the security and integrity of clinical trial data is propelling the growth of the market in this category.

These applications are covered:

• Clinical Data Exchange and Interoperability
• Claims Adjudication and Billing Management
• Drug Supply Chain Management (Largest Category)
• Drug Discovery and Clinical Trials (Fastest-Growing Category)
• Prescription Drug Abuse
• Others

End User Analysis

Pharmaceutical and medical device companies held the largest share in 2024, of 55%, because of their high R&D investments. Such projects mandate the safe and secure sharing of authentic information across various organizations. Hence, the adoption of this technology is growing for verifying the authenticity of the returned drug, preventing counterfeits from moving on to trials and, ultimately, to the market, ensuring compliance, transparency, and traceability within the pharmaceutical supply chain and in clinical trials, and improving the reliability and quality of the clinical trials.

The blockchain technology enables a holistic, efficient, and transparent environment in which patient records can be stored and tracked without being tampered with. These advantages make it a good choice in the pharmaceutical and healthcare industries to ensure compliance with the government regulations on drug and patient data safety.

Healthcare payers are the fastest-growing category on account of the increasing incidence of insurance fraud, which payers and governments are trying hard to counter. Blockchains ensure all financial transactions in the healthcare industry to be recorded securely and be made available to the concerned party, as needed. As per studies, between USD 80 and 260 billion is lost every year in health insurance fraud around the world.

These end users are covered:

• Pharmaceutical & Medical Device Companies (Largest Category)
• Healthcare Providers
• Healthcare Payers (Fastest-Growing Category)
• Others

Blockchain in Healthcare Market Geographical Analysis

Europe has the leading position in the blockchain market, and it will hold the same position till 2032, with 40% share. This is attributed to the existence of various IT vendors in the region and the rapid adoption of novel technologies, aided by the existence of highly efficient infrastructure.

Medical organizations and pharmaceutical companies in the region are experimenting with this technology to streamline their operations, improve efficiency, and control costs. The constant regulatory pressure to manage integrity and accuracy, as well as improving the overall patient experience, is compelling the U.S. healthcare industry to actively pursue this advanced technology.

The Asia-Pacific region is set to show the fastest development in the domain, with 55% CAGR, because of the large population, which results in the creation of huge volumes of patient records, which need to be protected at all costs. The market is also driven by the rapid acceptance of advanced technologies, in part, on account of the investments put in by the government for encouraging R&D in this field.

Essentially, the rapid advancement of the hospital infrastructure and digitization of records in the region are bringing such advanced technologies to life. Given the potential of this novel technology in boosting efficiency, improving security, easing transactions, and engaging patients, governments across APAC are promoting its usage and that of cryptocurrencies in the entire healthcare ecosystem.

The regions and countries analyzed for this report include:

• North America
  • U.S. (Larger and Faster-Growing Country Market)
  • Canada
• Europe (Largest Regional Market)
  • Germany (Largest Country Market)
  • U.K. (Fastest-Growing Country Market)
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • Japan
  • India (Fastest-Growing Country Market)
  • South Korea
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest and Fastest-Growing Country Market)
  • Mexico
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa
  • U.A.E. (Fastest-Growing Country Market)
  • Rest of MEA

Blockchain in Healthcare Market Share

• The market is fragmented as a large number of IT companies are working on and with blockchains for the healthcare sector.
• Further, the ledgers are jointly operated by all the entities involved, which means nobody has a strong say.
• Additionally, data protection regulations vary across countries, which is why a large number of IT vendors can offer solutions.
• Moreover, the solutions may need to be customized as per the exact use case, which further fragments the market.
• Most of the projects are at the pilot stage, which is why no single companies generates a lot of revenue.

Blockchain in Healthcare Market News & Updates

• In January 2025, IIT-BHU announced the development of a new technology based on ML and blockchain for the emergency departments of hospitals.
• In November 2024, Tassat Group Inc. entered into a partnership with Veuu to develop blockchain-driven solutions, to reduce healthcare insurance fraud.
• In March 2023, Vitraya Technologies, an Indian company developing blockchain solutions for healthcare claims processing, received USD 4.1 million in investment from Xceedance.